Lundbeck’s migraine prevention treatment sees ph. 2 success after trial’s earlier setback
Lundbeck’s migraine prevention treatment sees ph. 2 success after trial’s earlier setback
Body unavailable. Use the original source.
Lundbeck’s migraine prevention treatment sees ph. 2 success after trial’s earlier setback
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.